Insights

Innovative Gene Therapy Bamboo Therapeutics specializes in gene therapies derived from an exclusive rAAV platform, focusing on devastating neurological and neuromuscular diseases such as Duchenne muscular dystrophy, representing a promising area for collaboration and innovative treatment solutions.

Growing Investment With recent funding of $50 million and a revenue range of $1 million to $10 million, the company is expanding its research and development capabilities, presenting opportunities for strategic partnerships and increased sales volume.

Acquisition Backing As a wholly owned subsidiary of Pfizer Inc., Bamboo benefits from extensive resources and industry expertise, positioning it for accelerated product development and larger market penetration prospects.

Target Market Focus Focusing on rare neurological and neuromuscular diseases that impact children offers a niche market with high unmet medical needs, suitable for specialized healthcare providers and pharmaceutical partners aiming to expand their portfolio.

Manufacturing Capabilities The company's proprietary GMP vector manufacturing process and recent purchase of a scaled-up production facility enable reliable, compliant, and scalable production, which is essential for any sales strategy targeting large-volume or clinical-partner collaborations.

Similar companies to Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.

Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. Tech Stack

Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s Email Address Formats

Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. uses at least 2 format(s):
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. Email FormatsExamplePercentage
FLast@arenapharm.comJDoe@arenapharm.com
86%
FirLast@arenapharm.comJohDoe@arenapharm.com
4%
FirstLast@arenapharm.comJohnDoe@arenapharm.com
1%
First.Last@arenapharm.comJohn.Doe@arenapharm.com
2%
F.Last@arenapharm.comJ.Doe@arenapharm.com
1%
First_Last@arenapharm.comJohn_Doe@arenapharm.com
1%
Last.First@arenapharm.comDoe.John@arenapharm.com
1%
FiLast@arenapharm.comJoDoe@arenapharm.com
1%
LastFir@arenapharm.comDoeJoh@arenapharm.com
1%
FMLast@arenapharm.comJMDoe@arenapharm.com
1%
Last_First@arenapharm.comDoe_John@arenapharm.com
1%
FLast@bambootherapeutics.comJDoe@bambootherapeutics.com
100%

Frequently Asked Questions

Where is Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s headquarters located?

Minus sign iconPlus sign icon
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s main headquarters is located at 870 Martin Luther King Boulevard Chapel Hill, North Carolina 27517 United States. The company has employees across 5 continents, including North AmericaAsiaAfrica.

What is Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s official website is bambootherapeutics.com and has social profiles on LinkedInCrunchbase.

What is Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. has approximately 52 employees across 5 continents, including North AmericaAsiaAfrica. Key team members include Director Of Strategic Marketing: L. A.Marketing Director: H. S.Clinical Biomarker Project Manager Translational Sciences/Clinical Development: E. T.. Explore Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s employee directory with LeadIQ.

What industry does Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. belong to?

Minus sign iconPlus sign icon
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. operates in the Biotechnology Research industry.

What is Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s email format?

Minus sign iconPlus sign icon
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s email format typically follows the pattern of FLast@arenapharm.com. Find more Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. email formats with LeadIQ.

How much funding has Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. raised to date?

Minus sign iconPlus sign icon
As of February 2026, Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. has raised $50M in funding. The last funding round occurred on Feb 11, 2016 for $50M.

When was Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. founded?

Minus sign iconPlus sign icon
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. was founded in 2014.

Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.

Biotechnology ResearchNorth Carolina, United States51-200 Employees

Bamboo represents a community of researchers, clinicians, parents, regulatory scientists, and business professionals committed to providing hope to patients suffering from debilitating disease. Bamboo is focused on some of the most devastating neurological and neuromuscular diseases that affect children. Our lead therapeutic is a gene therapy product for the treatment of Duchenne muscular dystrophy. Bamboo's therapeutics are derived from an exclusive rAAV platform technology, and are manufactured using a proprietary scaled up process at an established GMP vector core facility recently purchased by the company.

Section iconCompany Overview

Headquarters
870 Martin Luther King Boulevard Chapel Hill, North Carolina 27517 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $50M

    Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. has raised a total of $50M of funding over 1 rounds. Their latest funding round was raised on Feb 11, 2016 in the amount of $50M.

  • $1M$10M

    Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $50M

    Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. has raised a total of $50M of funding over 1 rounds. Their latest funding round was raised on Feb 11, 2016 in the amount of $50M.

  • $1M$10M

    Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.